TRDA fundamentals

An in-depth look to Entrada Therapeutics, Inc. operating, investing, and financing activities

TRDA free cash flow for Q1 25 is -39.65 M USD. For 2024, TRDA free cash flow was -44.72 M USD and operating cash flow was -41.56 M USD.

Q3 '20

Q1 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Cash from operating activities

Cash from investing activities

Cash from financing activities

Currency: USD